- Browse by Subject
Browsing by Subject "Bone and Bones"
Now showing 1 - 10 of 15
Results Per Page
Sort Options
Item A Study of Skeletal Maturation in the Hand-Wrist Radiograph of Twins(1973) Susott, Kenton AlanBone ages were assessed using the hand-wrist r radiograph of 31 monozygotic twin pairs and 15 dizygotic twin pairs. Assessments were made on the right and left hand on two separate occasions. The method of assessment used was a modification of the Greulich and Pyle method. The measurement error for the assessments was 3.8 months and 4.1 months for the left and right hand respectively. No asymmetry was demonstrated between right and left sides. The four assessments were averaged to obtain a single bone age assessment for each individual. The ratio of the epiphyseal-metaphyseal width for the radius and ulna was proposed as a quantitative measurement which closely corresponds with the subjective bone age assessment. Correlation coefficients ranging from .84 to .90 were reported for the epiphyseal-metaphyseal ratios with bone age assessments. When the ratios were analyzed with respect to sex, correlation coefficients ranging from .89 to .94 were reported. The correlation of the ratios with bone age assessments was consistently greater in males than females. As tested by the F statistic, a significant amount of variation in bone age and ulna epiphyseal-metaphyseal ratio could be attributed to the heritability fraction. Using the Holzinger formula, 82% of the bone age assessment and 88% of the ulna ratio could be attributed to the heritability fraction.Item Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels(Endocrine Society, 2017-05-01) Knab, Vanessa M.; Corbin, Braden; Andrukhova, Olena; Hum, Julia M.; Ni, Pu; Rabadi, Seham; Maeda, Akira; White, Kenneth E.; Erben, Reinhold G.; Jüppner, Harald; Christov, Marta; Medical and Molecular Genetics, School of MedicineThe acute effects of parathyroid hormone (PTH) on fibroblast growth factor 23 (FGF23) in vivo are not well understood. After a single subcutaneous PTH (1-34) injection (50 nmol/kg) in mice, FGF23 levels were assessed in plasma using assays that measure either intact alone (iFGF23) or intact/C-terminal FGF23 (cFGF23). Furthermore, FGF23 messenger RNA (mRNA) and protein levels were assessed in bone. In addition, we examined the effects of PTH treatment on FGF23 production in vitro using differentiated calvarial osteocyte-like cells. cFGF23 levels increased by three- to fivefold within 2 hours following PTH injection, which returned to baseline by 4 hours. In contrast, iFGF23 levels remained unchanged for the first 2 hours, yet declined to ∼60% by 6 hours and remained suppressed before returning to baseline after 24 hours. Using homozygous mice for an autosomal dominant hypophosphatemic rickets-FGF23 mutation or animals treated with a furin inhibitor, we showed that cFGF23 and iFGF23 levels increased equivalently after PTH injection. These findings are consistent with increased FGF23 production in bone, yet rapid cleavage of the secreted intact protein. Using primary osteocyte-like cell cultures, we showed that PTH increased FGF23 mRNA expression through cyclic adenosine monophosphate/protein kinase A, but not inositol triphosphate/protein kinase C signaling; PTH also increased furin protein levels. In conclusion, PTH injection rapidly increases FGF23 production in bone in vivo and in vitro. However, iFGF23 is rapidly degraded. At later time points through an unidentified mechanism, a sustained decrease in FGF23 production occurs.Item The Axolotl Fibula as a Model for the Induction of Regeneration across Large Segment Defects in Long Bones of the Extremities(Public Library of Science, 2015) Chen, Xiaoping; Song, Fengyu; Jhamb, Deepali; Li, Jiliang; Bottino, Marco C.; Palakal, Mathew J.; Stocum, David L.; Department of Biology, School of ScienceWe tested the ability of the axolotl (Ambystoma mexicanum) fibula to regenerate across segment defects of different size in the absence of intervention or after implant of a unique 8-braid pig small intestine submucosa (SIS) scaffold, with or without incorporated growth factor combinations or tissue protein extract. Fractures and defects of 10% and 20% of the total limb length regenerated well without any intervention, but 40% and 50% defects failed to regenerate after either simple removal of bone or implanting SIS scaffold alone. By contrast, scaffold soaked in the growth factor combination BMP-4/HGF or in protein extract of intact limb tissue promoted partial or extensive induction of cartilage and bone across 50% segment defects in 30%-33% of cases. These results show that BMP-4/HGF and intact tissue protein extract can promote the events required to induce cartilage and bone formation across a segment defect larger than critical size and that the long bones of axolotl limbs are an inexpensive model to screen soluble factors and natural and synthetic scaffolds for their efficacy in stimulating this process.Item Bone and skeletal muscle: Key players in mechanotransduction and potential overlapping mechanisms(Elsevier, 2015-11) Goodman, Craig A.; Hornberger, Troy A.; Robling, Alexander G.; Department of Anatomy & Cell Biology, IU School of MedicineThe development and maintenance of skeletal muscle and bone mass is critical for movement, health and issues associated with the quality of life. Skeletal muscle and bone mass are regulated by a variety of factors that include changes in mechanical loading. Moreover, bone mass is, in large part, regulated by muscle-derived mechanical forces and thus by changes in muscle mass/strength. A thorough understanding of the cellular mechanism(s) responsible for mechanotransduction in bone and skeletal muscle is essential for the development of effective exercise and pharmaceutical strategies aimed at increasing, and/or preventing the loss of, mass in these tissues. Thus, in this review we will attempt to summarize the current evidence for the major molecular mechanisms involved in mechanotransduction in skeletal muscle and bone. By examining the differences and similarities in mechanotransduction between these two tissues, it is hoped that this review will stimulate new insights and ideas for future research and promote collaboration between bone and muscle biologists.(1).Item Cx43 and mechanotransduction in bone(Springer-Verlag, 2015-04) Plotkin, Lilian I.; Speacht, Toni L.; Donahue, Henry J.; Department of Anatomy & Cell Biology, IU School of MedicineBone adaptation to changes in mechanical stimuli occurs by adjusting bone formation and resorption by osteoblasts and osteoclasts, to maintain optimal bone mass. Osteocytes coordinate the actions of these cells on the bone surface by sensing mechanical forces and producing cytokines that increase or prevent osteoblast and osteoclast differentiation and function. Channels formed by connexins (Cxs) and, in particular, connexin 43 (Cx43) in osteoblasts and osteocytes are central part of this mechanism to control bone mass. Cx43 hemichannels are opened by fluid flow and mediate the anti-apoptotic effect of mechanical stimulation in vitro, suggesting that Cx43 participates in mechanotransduction. However, mice lacking Cx43 in osteoblasts and/or osteocytes show an increased anabolic response to loading and decreased catabolic response to unloading. This evidence suggests that Cx43 channels expressed in osteoblastic cells are not required for the response to mechanical stimulation, but mediate the consequence of lack thereof. The molecular basis of these unexpected responses to mechanical stimulation is currently under investigation.Item Differential effects of Epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model(Wiley Blackwell (John Wiley & Sons), 2016-04) Abeysekera, Irushi; Thomas, Jared; Georgiadis, Taxiarchis M.; Berman, Alycia G.; Hammond, Max A.; Dria, Karl J.; Wallace, Joseph M.; Roper, Randall J.; Department of Biology, School of ScienceSCOPE: Down syndrome (DS), caused by trisomy of human chromosome 21 (Hsa21), is characterized by a spectrum of phenotypes including skeletal abnormalities. The Ts65Dn DS mouse model exhibits similar skeletal phenotypes as humans with DS. DYRK1A, a kinase encoded on Hsa21, has been linked to deficiencies in bone homeostasis in DS mice and individuals with DS. Treatment with Epigallocatechin-3-gallate (EGCG), a known inhibitor of Dyrk1a, improves some skeletal abnormalities associated with DS in mice. EGCG supplements are widely available but the effectiveness of different EGCG-containing supplements has not been well studied. METHODS AND RESULTS: Six commercially available supplements containing EGCG were analyzed, and two of these supplements were compared with pure EGCG for their impact on skeletal deficits in a DS mouse model. The results demonstrate differential effects of commercial supplements on correcting skeletal abnormalities in Ts65Dn mice. Different EGCG-containing supplements display differences in degradation, polyphenol content, and effects on trisomic bone. CONCLUSION: This work suggests that the dose of EGCG and composition of EGCG-containing supplements may be important in correcting skeletal deficits associated with DS. Careful analyses of these parameters may lead to a better understanding of how to improve skeletal and other deficits that impair individuals with DS.Item Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodeling(Spandidos Publications, 2018-09) Wang, Luqi; Wang, Yue; Chen, Andy; Jalali, Aydin; Liu, Shengzhi; Guo, Yunxia; Na, Sungsoo; Nakshatri, Harikrishna; Li, Bai-Yan; Yokota, Hiroki; Biomedical Engineering, School of Engineering and TechnologyChemotherapy for suppressing tumor growth and metastasis tends to induce various effects on other organs. Using AZD7762, an inhibitor of checkpoint kinase (Chk) 1 and 2, the present study examined its effect on mammary tumor cells in addition to bone cells (osteoclasts, osteoblasts and osteocytes), using monolayer cell cultures and three-dimensional (3D) cell spheroids. The results revealed that AZD7762 blocked the proliferation of 4T1.2 mammary tumor cells and suppressed the development of RAW264.7 pre-osteoclast cells by downregulating nuclear factor of activated T cells cytoplasmic 1. AZD7762 also promoted the mineralization of MC3T3 osteoblast-like cells and 3D bio-printed bone constructs of MLO-A5 osteocyte spheroids. While a Chk1 inhibitor, PD407824, suppressed the proliferation of tumor cells and the differentiation of pre-osteoclasts, its effect on gene expression in osteoblasts was markedly different compared with AZD7762. Western blotting indicated that the stimulating effect of AZD7762 on osteoblast development was associated with the inhibition of Chk2 and the downregulation of cellular tumor antigen p53. The results of the present study indicated that in addition to acting as a tumor suppressor, AZD7762 may prevent bone loss by inhibiting osteoclastogenesis and stimulating osteoblast mineralization.Item The expanding role of Wnt signaling in bone metabolism(Elsevier B.V., 2013-07) Robling, Alexander G.; Department of Anatomy & Cell Biology, IU School of MedicineItem Histological and Mechanical Analysis of Bone/Implant Interface in Female Retired-Breeder Rabbits(1992) Bruch, Christopher G.; Roberts, W. Eugene; Garetto, Lawrence P.; Arbuckle, Gordon R.; Nelson, Charles L.; Shanks, James C.Endosseous implants have been accepted as a viable dental and medical adjunct and are now used for multiple dental applications. The majority are placed in patients of relatively advanced age, and, as such, the increased use of implants has raised questions in the areas of bone healing and metabolism associated with their placement. This study evaluated the mechanical and histological aspects of the bone/metal interface of endosseous titanium implants in compact and trabecular bone. Two implants were placed: one in the distal metaphysis (M) and one 2.0 cm proximal in the diaphysis (D). Right side limbs were subjected to a sham surgery and served as controls. The rabbits were sacrificed at six, 12, and 24 weeks healing time. Multiple fluorochrome labels were given to mark sites of bone formation. At sacrifice, all implants were tested for interface torque strength. Microradiography and fluorescent light microscopy were used to determine percent volume of bone and marrow space, bone/implant interface characteristics, percent labeled bone surface area, and percent labeled bone volume. D implants required about 20 percent more torque to mechanically disrupt the bone/implant interface than M implants. Values were M (combined groups) 33.4 N-cm ±15.5 N-cm, and D (combined groups) 41.5 N-cm ±16.0 N-cm (Mean ±SD, n = 8, p<.07). The percent of bone in direct contact with the implant surface appeared to increase only slightly with time. Direct contact occurred on 11.2%, 9.5% ±8.5% and 13.9% ±6.6% of the M implant surface in six, 12, and 24 week specimens, respectively. Direct contact occured on 11.7%, 10.2% ±2.4% and 19.5% ±0.35% of the D implant surface in six, 12, and 24 week specimens, respectively. Total bone volume in implanted D specimens was less [Exp.= 91.1% ± 3.1%, Cont. = 95.5% ± 0.73% (Mean ±SD)] and marrow space volume was greater [Exp. = 8.9% ±3.02%, Cont. = 4.6% ±0.73% (Mean ±SD)] than in controls (p<.02). The percent labeled bone volume was greater in the implanted specimens than in their controls (p<.001). This difference decreased over time. Implanted D specimens also showed significantly more (p<.001) labeled bone surface area than controls. These findings suggest that when implants are placed in elderly subjects, normally inactive bone becomes very active. Also, it seems that bone quality, not quantity, determines interface strength.Item Histomorphometric and Biomechanical Analyses of Osseointegration of Four Different Orthodontic Mini Implant Surfaces(2011) Yadav, Sumit; Roberts, W. Eugene, Jr.; Chen, Jie; Katona, Thomas R.; Liu, Sean S.; Huja, Sarandeep S. (Sarandeep Singh), 1965-Objective: To evaluate the osseointegration potential of four different surfaces of mini-implants .We hypothesized that mini-implants surface roughness alters the intrinsic biomechanical properties of the bone integrated to titanium. Materials and Methods: Mini implants and circular discs were made from alloy Ti6Al4V grade 5. On the basis of surface treatment study was divided into 4 groups: Group 1: Machined: no surface treatment, Group 2: Acid etched: with hydrochloric acid, Group 3: Grit Blasted with alumina and Group 4: Grit blasted +Acid etched. Surface roughness parameters (mean surface roughness: Ra and Quadratic Average roughness: Rq) of the four discs from each group were measured by the optical profilometer. Contact angle measurement of 3 discs from each group was done with a Goniometer. Contact angle of liquids with different hydrophobicity and hydrophilicity were measured. 128 mini implants, differing in surface treatment, were placed into the tibias and femurs of 8 adult male New Zealand white rabbits. Biomechanical properties (Removal torque and hardness) measurements and histomorphometric observations were measured. Results: Ra and Rq of groups were: Machined (1.17±0.11, 2.59±0.09) Acid etched (1.82±0.04, 3.17±0.13), Grit blasted (4.83±0.23, 7.04±0.08), Grit blasted + Acid etched (3.64±0.03, 4.95±0.04) respectively. Group 4 had significantly (p=0.000) lower Ra and Rq than Group 3. The interaction between the groups and liquid was significant. Group 4 had significantly lower contact angle measurements (40.4°, 26.9°), both for blood and NaCl when compared to other three groups (p≤0.01). Group 4 had significantly higher torque than Group 3 (Tibia: 13.67>9.07N-cm; Femur: 18.21>14.12N-cm), Group 4 (Tibia: 13.67>9.78N-cm; Femur: 18.21>12.87N-cm), and machined (Tibia: 13.67>4.08N-cm; Femur: 18.21>6.49N-cm). SEM analysis reveals significantly more bone implant gap in machined implant surfaces than treated implant surfaces. Bone to implant contact had significantly higher values for treated mini implant surface than machined surface. Hardness of the bone near the implant bone interface is 20 to 25% less hard than bone 1mm away from it in both Femur and Tibia. Conclusion: Surface roughness and wettability of mini implants influences their biological response. Grit blasted and acid etched mini implants had lowest contact angle for different liquids tested and highest removal torques.